As expected, inhibition of SIRT1 activity by its inhibitor, EX-527, attenuated TCO-induced autophagy, as evidenced by decreased LC3-II conversion and LC3 puncta in colorectal cancer cells (Figure 4C-4F). Here, MAP1LC3A is linked to colorectal cancer.